Lactobacillus rhamnosus GG के लिए Gut Immune Health

Q: Does Lactobacillus rhamnosus GG help with Gut Immune Health?

Based on 20 studies with 3,000 participants, there is moderate evidence from clinical studies that Lactobacillus rhamnosus GG may support Gut Immune Health management. Our evidence grade is B (Good Evidence).

Q: How much Lactobacillus rhamnosus GG should I take for Gut Immune Health?

Studies have used various dosages. A commonly studied range is 10-20 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Lactobacillus rhamnosus GG?

Reported side effects may include Mild bloating and gas (usually transient), Rare: bacteremia in severely immunocompromised patients, Generally very well tolerated. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Lactobacillus rhamnosus GG and Gut Immune Health?

We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

B संबंधित साक्ष्य कम से कम एक यादृच्छिक परीक्षण इसका समर्थन करता है, जिसके परिणाम अधिकतर सुसंगत हैं।

Systematic reviews demonstrate Lactobacillus rhamnosus GG supplementation may help reduce the incidence and duration of upper respiratory tract infections in children and adults. Additionally supports intestinal barrier function and recovery from antibiotic-associated diarrhea.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dlactobacillus\u002Drhamnosus\u002Dgg\u0026condition\u003Dgut\u002Dimmune\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

निष्कर्ष

Key Study Findings

Other

AhR ligands from LGG metabolites promote piglet intestinal ILC3 activation and IL-22 secretion to inhibit …

Dose: None बनाम: None Outcome: Gut microbiota composition प्रभाव: None None

जनसंख्या: Mouse model

In Vitro 2.7 weeks

Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection.

Dose: None बनाम: None Outcome: immune function प्रभाव: None p < 0.01

जनसंख्या: mice (animal model)

Randomized Controlled Trial n=96 52 weeks Double-blind

Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses.

Dose: Lactobacillus rhamnosus GG बनाम: Placebo Outcome: Gut microbiota and Ig-secreting cells प्रभाव: Higher IgG, IgM, IgA cells with probiotic+breastfeeding 0.005

जनसंख्या: Infants supplemented with probiotics during breastfeeding

Key Statistics

अध्ययन

3000

प्रतिभागी

↑

Positive

ग्रेड

Referenced Papers

AhR ligands from LGG metabolites promote piglet intestinal ILC3 activation and IL-22 secretion to inhibit PEDV infection. Other

Journal of virology 2024 9 उद्धरण

Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. Other

Letters in applied … 2010 126 उद्धरण

Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. RCT

The Journal of … 2005 178 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:: 10-20 billion CFU/day

अधिकतम सीमा: No established UL

अनुसंधान में अध्ययन की गई खुराकें

खुराक	अवधि	प्रभाव	N
None	--	Positive	--
None	2.7 weeks	Positive	--
Lactobacillus rhamnosus GG	52 weeks	Positive	96

सेवन का सर्वोत्तम समय: With or without food; consistency matters more than timing

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

⚠ Mild bloating and gas (usually transient)
⚠ Rare: bacteremia in severely immunocompromised patients
⚠ Generally very well tolerated

ज्ञात अंतःक्रियाएँ

● Antibiotics (may reduce probiotic effectiveness; space doses 2+ hours apart)
● Immunosuppressant medications (caution in severely immunocompromised patients)

सहनीय अधिकतम सेवन: No established UL

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Lactobacillus rhamnosus GG help with Gut Immune Health?

Based on 20 studies with 3,000 participants, there is moderate evidence from clinical studies that Lactobacillus rhamnosus GG may support Gut Immune Health management. Our evidence grade is B (Good Evidence).

How much Lactobacillus rhamnosus GG should I take for Gut Immune Health?

Studies have used various dosages. A commonly studied range is 10-20 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Lactobacillus rhamnosus GG?

Reported side effects may include Mild bloating and gas (usually transient), Rare: bacteremia in severely immunocompromised patients, Generally very well tolerated. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Lactobacillus rhamnosus GG and Gut Immune Health?

We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

इसके लिए अन्य सामग्री Gut Immune Health

Saccharomyces boulardii B

संक्षिप्त निष्कर्ष

Evidence Strength72%

High confidence

अध्ययन विश्लेषण

RCT (1)Meta (0)Other (19)

विकल्पों की तुलना करें

देखें कि इस स्वास्थ्य स्थिति के लिए अन्य सामग्री की तुलना कैसे है।

इसके लिए सभी सामग्री देखें Gut Immune Health

अधिक जानें

References

[1] Junhong Wang et al.. J Virol. 2024. AhR ligands from LGG metabolites promote piglet intestinal ILC3 activation and IL-22 secretion to inhibit PEDV infection. doi:10.1128/jvi.01039-24 PubMed
[2] M Kawase et al.. Lett Appl Microbiol. 2010. Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. doi:10.1111/j.1472-765X.2010.02849.x PubMed
[3] Minna Rinne et al.. J Pediatr. 2005. Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. doi:10.1016/j.jpeds.2005.03.053 PubMed

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।